Senya Therapeutics was awarded a £0.7 million grant from Innovate UK, the UK government’s innovation funding program. Recognized for its potential impact, Senya’s LRG1 program was selected in a highly competitive process where fewer than 10% of applicants received funding.

The grant will support the completion of preclinical programs for kidney and cancer therapeutics.